FIELD: oncology and molecular biology.
SUBSTANCE: invention relates to oncology and molecular biology. In the preoperative period, venous blood is examined by multicolor flow cytometry using monoclonal antibodies to EpCam, CD45, CD44, CD24, N-Cadherin labeled with various fluorochromes, and NucBlue Live cell stain ready probes reagent nuclear dye. Then determine the number of Epcam + CD45- (cells/ml of blood) (X1), the number of CTCs with the Epcam + CD45-CD44-CD24-Ncadherin + phenotype (cells/ml) (X2), the number of stem CTCs without Epcam expression on the membrane with the Epcam phenotype (m) -CD45-CD44 + CD24- (cells/ml) (X3); the number of atypical/hybrid forms of CTCs with the Epcam + CD45 + phenotype (cells/ml) (X4). Then the value of the regression equation Υ is calculated according to the original formula. At Υ≥0.5, a high is determined, and at Υ<0.5, a low risk of endometrial cancer recurrence is determined.
EFFECT: method allows to reduce invasiveness and increase the accuracy, sensitivity and specificity of the method by 87.5% and 96.7%, respectively.
1 cl, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREDICTING HEMATOGENOUS METASTASIS IN INVASIVE CARCINOMA OF NONSPECIFIC TYPE OF MAMMARY GLAND BASED ON DETERMINATION OF DIFFERENT POPULATIONS OF CIRCULATING TUMOR CELLS IN BLOOD BEFORE TREATMENT | 2018 |
|
RU2678202C1 |
METHOD FOR PREDICTING THE RISK OF POOR TUMOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH INVASIVE BREAST CANCER | 2018 |
|
RU2682967C1 |
METHOD FOR PREDICTION OF RISK OF TUMOUR PROGRESSION IN PATIENTS WITH OVARIAN CANCER | 2023 |
|
RU2816339C1 |
METHOD OF PREDICTING RISK OF EARLY RECURRENCE OF ENDOMETRIAL SQUAMOUS CELL CARCINOMA IN PATIENTS WITH STAGE I OF DISEASE | 2023 |
|
RU2812609C1 |
USE OF O-ACETYLATED GD2 GANGLIOSIDE AS TARGET AS NOVEL THERAPEUTIC AND DIAGNOSTIC APPROACH IN MALIGNANT GROWTHS CONTAINING TUMOUR STEM CELLS | 2014 |
|
RU2702428C2 |
METHOD FOR PREDICTION OF RADIOSENSITIVITY OF MALIGNANT GROWTHS OF UPPER RESPIRATORY TRACT | 2020 |
|
RU2735982C2 |
METHOD FOR PREDICTION OF HEMATOGENOUS METASTASIS IN INVASIVE BREAST CARCINOMA | 2021 |
|
RU2787170C1 |
COMPOSITIONS AND METHODS OF TREATING CANCER | 2016 |
|
RU2729396C2 |
METHOD FOR PREDICTING THE RISK OF AN UNFAVORABLE OUTCOME OF COLON AND RECTOSIGMOID CANCER | 2021 |
|
RU2772207C1 |
METHOD FOR DETERMINING CIRCULATING TUMOR CELLS IN PATIENTS WITH BREAST CANCER | 2021 |
|
RU2770284C1 |
Authors
Dates
2021-12-21—Published
2021-05-25—Filed